Spinal Cord Area Loss Predicts Myelopathy in Severe Cervical Ossification

Refining Radiological Assessment in Cervical Ossification

Degenerative cervical myelopathy remains the leading cause of spinal cord dysfunction in adults, often necessitating complex surgical decisions as the global population ages [1, 2]. In cases of ossification of the posterior longitudinal ligament, clinicians frequently face a disconnect between the degree of bony stenosis seen on imaging and the patient's actual neurological status. Traditional metrics focusing on the spinal canal dimensions often fail to account for the intrinsic resilience or vulnerability of the neural tissue itself [3]. While dynamic imaging has improved the detection of motion-induced compression, the search for a reliable, static radiological marker that correlates with clinical impairment continues [4]. Identifying such predictors is essential, as preoperative symptom severity and the duration of compression are the most significant determinants of postoperative recovery [5]. A new study now evaluates whether cord-specific measurements can bridge the gap between radiological findings and clinical myelopathy.

Quantifying Cord Compression in Severe Disease

The researchers conducted a retrospective review of 300 patients with severe cervical ossification of the posterior longitudinal ligament, a condition characterized by the pathological calcification of the ligamentous tissue posterior to the vertebral bodies. For the purposes of this Class III evidence study, the authors defined severe disease as an occupying ratio greater than 50%, meaning the ossified mass obstructed more than half of the available spinal canal diameter. This specific cohort was selected to address the frequent clinical discrepancy between high-grade stenosis and varying degrees of neurological impairment, a phenomenon where some patients with narrow canals remain asymptomatic while others with less stenosis suffer significant deficits. To identify the most accurate predictors of clinical status, the study compared several radiological metrics, including the occupying ratio, the space available for the spinal cord (the absolute distance between the posterior surface of the ossified mass and the anterior surface of the lamina), and the cord compression ratio. The researchers also evaluated the compressed spinal cord cross-sectional area and the %decreased spinal cord area (SCA). The %decreased SCA is a cord-specific measurement defined as the percentage reduction from the normal area, providing a normalized assessment of how much the neural tissue has actually shrunken relative to its predicted baseline. The clinical endpoint for the study was the presence and severity of myelopathy, which the researchers defined as a modified Japanese Orthopaedic Association (mJOA) score of 17 or less. The mJOA is a 17-point clinical scale used to quantify motor and sensory function in the upper and lower extremities as well as bladder control. By correlating the radiological measurements against this standardized clinical score, the study aimed to determine which imaging parameters most reliably reflect the functional deficits experienced by patients with high-grade ligamentous ossification.

Diagnostic Superiority of Cord-Specific Metrics

The researchers found that the percentage reduction from normal spinal cord area, or %decreased spinal cord area (SCA), was the most precise indicator of clinical myelopathy among all radiological parameters evaluated. This metric demonstrated the highest diagnostic accuracy with an area under the curve (AUC) of 0.904 (95% CI: 0.863-0.941). The AUC is a statistical measure of how effectively a diagnostic test distinguishes between two groups (in this case, patients with and without myelopathy), where a value of 1.0 represents a perfect test. This performance was significantly superior to traditional bony canal measurements, such as the occupying ratio, which yielded an AUC of 0.717, and the space available for the spinal cord, which showed an AUC of 0.751. These findings suggest that focusing on the actual neural tissue deformation provides a more reliable clinical picture than measuring the dimensions of the surrounding ossified mass or the remaining canal space, as the latter does not account for individual variations in cord size. To assist in clinical decision-making, the study identified an optimal cutoff for %decreased SCA of 15.2% to identify patients with a modified Japanese Orthopaedic Association score of 17 or less. At this 15.2% threshold, the metric achieved a sensitivity of 82.3% and a specificity of 91.8%, indicating a high degree of reliability in both identifying affected patients and correctly ruling out myelopathy in those without significant cord loss. The diagnostic utility of this cord-specific measurement remained robust even when assessing more severe clinical impairment; for moderate myelopathy, defined as a modified Japanese Orthopaedic Association score of 14 or less, the %decreased SCA demonstrated an even higher discriminative performance with an AUC of 0.931 at a cutoff of 16.3%.

Predicting Severity and Moderate Impairment

The diagnostic utility of cord-specific measurements remains robust when clinicians assess patients with more advanced clinical impairment. For those presenting with moderate myelopathy, defined as a modified Japanese Orthopaedic Association (mJOA) score of 14 or less, the %decreased spinal cord area (SCA) demonstrated an even higher discriminative performance with an area under the curve (AUC) of 0.931. This increased accuracy suggests that as the disease progresses, the reduction in cord area becomes an increasingly precise marker of functional status. To identify this moderate level of impairment, the researchers established an optimal cutoff of a 16.3% decrease in SCA, providing a specific radiological threshold for clinicians to consider when evaluating patients for surgical intervention or intensive monitoring. Beyond its diagnostic accuracy, the %decreased SCA showed the strongest correlation with clinical symptoms among all studied metrics, with a Spearman rho (ρ) of −0.772 (P < .001). This inverse relationship indicates that as the percentage of cord area loss increases, the mJOA score consistently declines. In a multivariate analysis (a statistical method used to determine the independent effect of a single variable while controlling for other factors), the %decreased SCA emerged as the most significant independent predictor of myelopathy severity, with a beta coefficient (β) of −0.118 per 1% increase (P < .001). This finding quantifies the clinical impact of tissue loss, suggesting that for every 1% reduction in the cross-sectional area of the spinal cord, there is a measurable and predictable decline in the patient's functional score. These data emphasize that the degree of intrinsic cord compression, rather than the size of the ossified mass itself, is the primary driver of neurological deficit in severe cervical ossification.

Multifactorial Drivers of Neurological Decline

While the reduction in spinal cord area serves as a primary metric for assessing disease, the study identified several other critical variables that contribute to the clinical presentation of myelopathy. The researchers found that T2 signal change (areas of hyperintensity on MRI indicating underlying cord edema or myelomalacia) was an independent factor associated with myelopathy severity. This finding suggests that the presence of intrinsic tissue damage provides prognostic value that complements the quantitative measurements of cord compression. Furthermore, OPLL morphology (the specific shape and configuration of the ossified mass) was also identified as an independent factor associated with myelopathy severity, indicating that the physical architecture of the ossification influences the degree of neurological impairment independently of the total space it occupies. The analysis also highlighted the role of mechanical and patient-specific variables in determining functional outcomes. Increased local range of motion (the degree of movement at the specific spinal segment affected by the ossification) was an independent factor associated with myelopathy severity, suggesting that dynamic instability or repetitive micro-trauma during neck movement may exacerbate cord injury in the presence of severe stenosis. Additionally, the researchers noted that male sex was an independent factor associated with myelopathy severity, pointing toward a demographic component in the risk profile for advanced disease. These findings collectively indicate that clinicians must look beyond static canal dimensions to a multifactorial model that includes cord signal characteristics, ossification shape, segmental mobility, and patient sex when assessing the risk of neurological decline and determining the necessity of surgical decompression.

References

1. Nagoshi N, Kawaguchi Y. Future perspectives after the guidelines of degenerative cervical myelopathy: A narrative review. Journal of Clinical Orthopaedics and Trauma. 2025. doi:10.1016/j.jcot.2025.103104

2. Lu Y, Shang Z, Zhang W, et al. Global incidence and characteristics of spinal cord injury since 2000–2021: a systematic review and meta-analysis. BMC Medicine. 2024. doi:10.1186/s12916-024-03514-9

3. Singh A, Tetreault L, Fehlings MG, Fischer DJ, Skelly AC. Risk factors for development of cervical spondylotic myelopathy: results of a systematic review. Evidence-Based Spine-Care Journal. 2013. doi:10.1055/s-0032-1327808

4. Baram A, Choueiri JE, Brembilla C, et al. Dynamic MRI in Degenerative Cervical Myelopathy: A Systematic Review of Radiological Markers, Correlations, and Outcomes.. Journal of clinical medicine. 2025. doi:10.3390/jcm15010265

5. Tetreault L, Karpova A, Fehlings MG. Predictors of outcome in patients with degenerative cervical spondylotic myelopathy undergoing surgical treatment: results of a systematic review. European Spine Journal. 2013. doi:10.1007/s00586-013-2658-z